Active Ingredient : 2-Deoxy-2-[¹⁸F] fluoro-D-glucose
Indications: Detection of lung cancer, colorectal cancer, lymphoma, melanoma, coronary artery disease, and epilepsy.
In clinical practice, non-invasive molecular imaging diagnosis has yielded exceptional results across a wide range of primary cancers. Even at the early stages of a lesion, Fluorine-18 Fluorodeoxyglucose ([¹⁸F]-FDG) can track and detect glucose metabolism within human cells. Powered by advanced molecular imaging technology, it provides physicians with the critical insights needed to achieve an accurate diagnosis.

• Early & Precise Detection: Sensitively captures abnormal glucose metabolism at the cellular level, even in the early stages of lesions.
• Broad Clinical Applications: It provides accurate diagnosis for various cancers (e.g., lung and colorectal cancers), coronary artery disease, and epilepsy.
• Optimized Therapeutic Decisions: Empowers physicians with critical insights for more accurate disease staging, treatment response monitoring, and therapy planning.